Palatin Technologies, Inc. (PTN)
NYSEAMERICAN: PTN · Real-Time Price · USD
19.35
+1.76 (10.01%)
Feb 18, 2026, 4:00 PM EST - Market closed
Palatin Technologies Market Cap
Palatin Technologies has a market cap or net worth of $31.82 million as of February 19, 2026. Its market cap has increased by 78.78% in one year.
Market Cap
31.82M
Enterprise Value
17.70M
1-Year Change
78.78%
Ranking
Category
Stock Price
$19.35
Market Cap Chart
Since December 1, 1998, Palatin Technologies's market cap has increased from $18.60M to $31.82M, an increase of 71.09%. That is a compound annual growth rate of 1.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 31.20M | 19.08% |
| Dec 31, 2025 | 26.20M | 20.74% |
| Dec 31, 2024 | 21.70M | -60.33% |
| Dec 29, 2023 | 54.70M | 106.42% |
| Dec 30, 2022 | 26.50M | -77.62% |
| Dec 31, 2021 | 118.40M | -23.81% |
| Dec 31, 2020 | 155.40M | -13.28% |
| Dec 31, 2019 | 179.20M | 24.53% |
| Dec 31, 2018 | 143.90M | -11.99% |
| Dec 29, 2017 | 163.50M | 199.45% |
| Dec 30, 2016 | 54.60M | 20.80% |
| Dec 31, 2015 | 45.20M | 56.94% |
| Dec 31, 2014 | 28.80M | - |
| Dec 31, 2013 | 28.80M | 23.08% |
| Dec 31, 2012 | 23.40M | 67.14% |
| Dec 30, 2011 | 14.00M | -12.50% |
| Dec 31, 2010 | 16.00M | -54.93% |
| Dec 31, 2009 | 35.50M | 355.13% |
| Dec 31, 2008 | 7.80M | -54.12% |
| Dec 31, 2007 | 17.00M | -88.28% |
| Dec 29, 2006 | 145.10M | -24.27% |
| Dec 30, 2005 | 191.60M | 33.43% |
| Dec 31, 2004 | 143.60M | 28.56% |
| Dec 31, 2003 | 111.70M | 197.87% |
| Dec 31, 2002 | 37.50M | -20.21% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rein Therapeutics | 29.44M |
| BriaCell Therapeutics | 29.28M |
| AN2 Therapeutics | 29.18M |
| Cue Biopharma | 28.11M |
| Passage Bio | 28.00M |
| Evaxion | 27.77M |
| IO Biotech | 26.59M |
| Lixte Biotechnology Holdings | 26.57M |